
Please try another search
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.
Name | Age | Since | Title |
---|---|---|---|
John Davies | - | 2022 | Independent Chairman |
Bola Grace | - | 2023 | Independent Director |
Hugh McNaught | - | 2020 | VP of Marketing & Member of Advisory Board |
Martha Najib | - | 2023 | Independent Director |
Martin Cronin | 57 | - | Independent Director |
Michael Edward Shannon | 76 | 2022 | Chair of Clinical Advisory Board |
Brian Firth | - | 2022 | CEO & Director |
Robert Crandall Greene | - | 2020 | CTO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review